Urologix, Inc. (ULGX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Aug 1, 2025
Paramount Global Market Cap
Urologix has a market cap or net worth of $2.13 thousand as of August 13, 2025. Its market cap has decreased by -98.84% in one year.
Market Cap
2.13K
Enterprise Value
n/a
Revenue
12.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 30, 1996, Urologix's market cap has decreased from 18.27M to 2.13K, a decrease of -99.99%. That is a compound annual growth rate of -26.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.13K | - |
| Dec 20, 2024 | 2.13K | 10,033.33% |
| Dec 20, 2023 | 21.00 | -99.01% |
| Dec 30, 2022 | 2.13K | 10,033.33% |
| Dec 31, 2021 | 21.00 | -99.98% |
| Dec 31, 2020 | 91.30K | -4.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| American Oncology Network | 393.37M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.75M |